Dermatomyositis Trials in Boston, United States
Conditions / Dermatomyositis / Boston, United States
Clinical trials for Dermatomyositis investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06154252 | RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy | RECRUITING | — |
| NCT05523167 | A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT05192200 | An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study | COMPLETED | PHASE2 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT00106184 | Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) | COMPLETED | PHASE2 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT03181893 | A Study In Adults With Moderate To Severe Dermatomyositis | COMPLETED | PHASE2 |
| NCT05437263 | A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02971683 | Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy | COMPLETED | PHASE3 |
| NCT02612857 | Trial of IMO-8400 in Adult Patients With Dermatomyositis | COMPLETED | PHASE2 |